Abstract
Colorectal cancer (CRC) remains a substantial public health challenge globally and is the second leading cause of cancer-related death in the USA. Despite advances in screening and treatment, disparities in CRC outcomes persist, especially among Black individuals in the USA, who face higher CRC incidence and mortality and lower survival compared with White individuals. Inequities are largely attributed to social determinants of health (SDOH), such as access to health care, socioeconomic conditions and systemic inequities. In this Review, we examine Black–White disparities in CRC outcomes across the CRC care continuum in the USA, highlighting contributing modifiable (non-biological) and non-modifiable (biological) risk factors. We also discuss successful interventions that have reduced or eliminated disparities. Existing evidence suggests that Black–White differences in CRC screening participation, CRC incidence and CRC mortality can be resolved. Future efforts must emphasize improving access to screening and guideline-concordant treatment to achieve progress in the near term while addressing the underlying and historical SDOH that drive inequities to eliminate disparities in the long term. The Review underscores the need for sustained investment in addressing both immediate and systemic barriers to CRC screening and care in Black communities to eliminate disparities in CRC outcomes and improve the overall health of the nation.
Key points
-
Colorectal cancer (CRC) disproportionately affects Black individuals in the USA, who experience higher incidence and mortality, and lower survival rates than White individuals despite an overall decline in incidence.
-
Social determinants of health (SDOH) are structural, economic, social and environmental factors that drive disparities in CRC outcomes by affecting access to health care, participation in screening and receipt of timely, high-quality care.
-
Modifiable CRC risk factors that result from adverse SDOH and contribute to inequities include medical comorbidities more common in Black individuals, low participation in CRC screening and low receipt of guideline-concordant treatment.
-
There are limited data supporting biological factors as drivers of disparities, and observed Black–White biological differences in CRC outcomes are probably influenced by mechanisms through which social factors affect health.
-
Successful interventions that target SDOH and modifiable risk factors, such as screening participation, demonstrate that the reduction and elimination of Black–White disparities in CRC screening and CRC outcomes are achievable.
-
A dual approach focusing on near-term improvements in access to screening and care and long-term interventions addressing SDOH is essential to eliminate Black–White inequities in CRC outcomes and to reduce the overall effect of CRC.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$32.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout






Similar content being viewed by others
Data availability
Databases referred to in Fig. 2 can be accessed from the Surveillance, Epidemiology, and End Results (SEER) 8 registries program (https://seer.cancer.gov/data). Databases referred to in Figs. 3, 5 and 6 can be accessed from the National Cancer Institute mortality database (https://seer.cancer.gov/mortality). Databases referred to in Fig. 4 can be accessed from the SEER 8 areas for 1975–1981 and SEER 12 areas for 1992–1998 and 2013–2019 (https://seer.cancer.gov/data).
References
Bray, F. et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 74, 229–263 (2024).
GBD 2019 Colorectal Cancer Collaborators Global, regional, and national burden of colorectal cancer and its risk factors, 1990–2019: a systematic analysis for the Global burden of disease study 2019. Lancet Gastroenterol. Hepatol. 7, 627–647 (2022); erratum 7, 704 (2022).
Siegel, R. L., Wagle, N. S., Cercek, A., Smith, R. A. & Jemal, A. Colorectal cancer statistics, 2023. CA Cancer J. Clin. 73, 233–254 (2023).
Gupta, S., May, F. P., Kupfer, S. S. & Murphy, C. C. Birth cohort colorectal cancer (CRC): implications for research and practice. Clin. Gastroenterol. Hepatol. 22, 455–469.e7 (2024).
Alsakarneh, S. et al. Disparities in colorectal cancer incidence in the United States, 2000-2019. Gastro Hep Adv. 3, 562–564 (2024).
Carethers, J. M. & Doubeni, C. A. Causes of socioeconomic disparities in colorectal cancer and intervention framework and strategies. Gastroenterology 158, 354–367 (2020).
Lorentsen, M. K. & Sanoff, H. K. Social determinants of health and the link to colorectal cancer outcomes. Curr. Treat. Options Oncol. 25, 453–464 (2024).
Zauber, A. G. The impact of screening on colorectal cancer mortality and incidence: has it really made a difference? Dig. Dis. Sci. 60, 681–691 (2015).
Schneider, M. Census data: US is diversifying, white population shrinking. Associated Press https://apnews.com/article/race-and-ethnicity-census-2020-7264a653037e38df7ba67d3a324fc90d (2021).
Braveman, P. A. et al. Health disparities and health equity: the issue is justice. Am. J. Public Health 101, S149–S155 (2011).
Commission on Social Determinants of Health. Closing the Gap in a Generation: Health Equity Through Action on the Social Determinants of Health (WHO, 2008).
Dahlgren, G. & Whitehead, M. Policies and Strategies to Promote Social Equity in Health. Background Document to WHO — Strategy Paper for Europe (Institute for Futures Studies, 1991).
Solar, O. & Irwin A. A Conceptual Framework for Action on the Social Determinants of Health. Social Determinants of Health Discussion Paper 2 (Policy and Practice) (WHO, 2010).
Bharmal, N., Derose, K. P., Felician, M. F. & Weden, M. M. Understanding the upstream social determinants of health. RAND https://www.rand.org/pubs/working_papers/WR1096.html (2015).
Thimm-Kaiser, M., Benzekri, A. & Guilamo-Ramos, V. Conceptualizing the mechanisms of social determinants of health: a heuristic framework to inform future directions for mitigation. Milbank Q. 101, 486–526 (2023).
Institute of Medicine (US) Committee on Understanding and Eliminating Racial and Ethnic Disparities in Health Care. Unequal Treatment: Confronting Racial and Ethnic Disparities in Health Care (eds Smedley, B. D., Stith, A. Y. & Nelson, A. R.) (National Academies, 2003).
Giaquinto, A. N. et al. Cancer statistics for African American/Black people 2022. CA Cancer J. Clin. 72, 202–229 (2022).
Brown, M. L. & Potosky, A. L. The presidential effect: the public health response to media coverage about Ronald Reagan’s colon cancer episode. Public Opin. Q. 54, 317–329 (1990).
Jepson, C., Kessler, L. G., Portnoy, B. & Gibbs, T. Black–white differences in cancer prevention knowledge and behavior. Am. J. Public Health 81, 501–504 (1991).
Chu, K. C., Tarone, R. E., Chow, W. H. & Alexander, G. A. Colorectal cancer trends by race and anatomic subsites, 1975 to 1991. Arch. Fam. Med. 4, 849–856 (1995).
Cram, P. et al. The impact of a celebrity promotional campaign on the use of colon cancer screening: the Katie Couric effect. Arch. Intern. Med. 163, 1601–1605 (2003).
Doubeni, C. A. et al. Racial and ethnic trends of colorectal cancer screening among Medicare enrollees. Am. J. Prev. Med. 38, 184–191 (2010).
Kahlam, A., Chowdhury, S., Kahlam, J., Amer, K. & Ahlawat, S. The Boseman effect: a missed opportunity? Cureus 14, e24959 (2022).
Cohen, S. A., Nash, C. C., Byrne, E. N., Mitchell, L. E. & Greaney, M. L. Black/White disparities in obesity widen with increasing rurality: evidence from a national survey. Health Equity 6, 178–188 (2022).
Thompson, T. L., Singleton, C. R., Springfield, S. E., Thorpe, R. J. Jr. & Odoms-Young, A. Differences in nutrient intake and diet quality between non-Hispanic black and non-Hispanic white men in the United States. Public Health Rep. 135, 334–342 (2020).
Tao, M. H., Liu, J. L. & Nguyen, U. D. T. Trends in diet quality by race/ethnicity among adults in the United States for 2011-2018. Nutrients 14, 4178 (2022).
Davis, J. S. et al. Use of non-steroidal anti-inflammatory drugs in US adults: changes over time and by demographic. Open Heart 4, e000550 (2017).
Zhang, J. et al. Effectiveness of screening modalities in colorectal cancer: a network meta-analysis. Clin. Colorectal Cancer 16, 252–263 (2017).
Kahi, C. J. et al. Colonoscopy and colorectal cancer mortality in the Veterans Affairs health care system: a case-control study. Ann. Intern. Med. 168, 481–488 (2018).
Koyama, A. K. et al. Prevalence of cardiometabolic diseases among racial and ethnic subgroups in adults — behavioral risk factor surveillance system, United States, 2013–2021. MMWR Morb. Mortal. Wkly Rep. 73, 51–56 (2024).
Yothers, G. et al. Outcomes among black patients with stage II and III colon cancer receiving chemotherapy: an analysis of ACCENT adjuvant trials. J. Natl Cancer Inst. 103, 1498–1506 (2011).
Murphy, N. et al. Heterogeneity of colorectal cancer risk factors by anatomical subsite in 10 European countries: a multinational cohort study. Clin. Gastroenterol. Hepatol. 17, 1323–1331.e6 (2019).
Wang, L. et al. Risk factor profiles differ for cancers of different regions of the colorectum. Gastroenterology 159, 241–256.e13 (2020).
Ugai, T. et al. Is early-onset cancer an emerging global epidemic? Current evidence and future implications. Nat. Rev. Clin. Oncol. 19, 656–673 (2022).
Saraiva, M. R., Rosa, I. & Claro, I. Early-onset colorectal cancer: a review of current knowledge. World J. Gastroenterol. 29, 1289–1303 (2023).
[No authors listed] NIH consensus conference. Adjuvant therapy for patients with colon and rectal cancer. JAMA 264, 1444–1450 (1990).
Potosky, A. L., Harlan, L. C., Kaplan, R. S., Johnson, K. A. & Lynch, C. F. Age, sex, and racial differences in the use of standard adjuvant therapy for colorectal cancer. J. Clin. Oncol. 20, 1192–1202 (2002).
Laiyemo, A. O. et al. Race and colorectal cancer disparities: health-care utilization vs different cancer susceptibilities. J. Natl Cancer Inst. 102, 538–546 (2010).
Breslin, T. M. et al. Hospital factors and racial disparities in mortality after surgery for breast and colon cancer. J. Clin. Oncol. 27, 3945–3950 (2009).
Star, J. et al. Updated review of major cancer risk factors and screening test use in the United States, with a focus on changes during the COVID-19 pandemic. Cancer Epidemiol. Biomark. Prev. 32, 879–888 (2023).
Grubbs, S. S. et al. Eliminating racial disparities in colorectal cancer in the real world: it took a village. J. Clin. Oncol. 31, 1928–1930 (2013).
Naishadham, D., Lansdorp-Vogelaar, I., Siegel, R., Cokkinides, V. & Jemal, A. State disparities in colorectal cancer mortality patterns in the United States. Cancer Epidemiol. Biomark. Prev. 20, 1296–1302 (2011).
Lauby-Secretan, B. et al. Body fatness and cancer – viewpoint of the IARC Working Group. N. Engl. J. Med. 375, 794–798 (2016).
Ye, P., Xi, Y., Huang, Z. & Xu, P. Linking obesity with colorectal cancer: epidemiology and mechanistic insights. Cancers 12, 1408 (2020).
Ma, Y. et al. Type 2 diabetes and risk of colorectal cancer in two large U.S. prospective cohorts. Br. J. Cancer 119, 1436–1442 (2018).
Wheat, C. L. et al. Worldwide incidence of colorectal cancer, leukemia, and lymphoma in inflammatory bowel disease: an updated systematic review and meta-analysis. Gastroenterol. Res. Pract. 2016, 1632439 (2016).
Garland, C. F. et al. Serum 25-hydroxyvitamin D and colon cancer: eight-year prospective study. Lancet 2, 1176–1178 (1989).
Yang, T. et al. Work stress and the risk of cancer: a meta-analysis of observational studies. Int. J. Cancer 144, 2390–2400 (2019).
Lofton, H., Ard, J. D., Hunt, R. R. & Knight, M. G. Obesity among African American people in the United States: a review. Obesity 31, 306–315 (2023).
Parker, E. D. et al. Economic costs of diabetes in the U.S. in 2022. Diabetes Care 47, 26–43 (2024).
Cui, A. et al. Prevalence, trend, and predictor analyses of vitamin D deficiency in the US population, 2001-2018. Front. Nutr. 9, 965376 (2022).
Chida, Y., Hamer, M., Wardle, J. & Steptoe, A. Do stress-related psychosocial factors contribute to cancer incidence and survival? Nat. Clin. Pract. Oncol. 5, 466–475 (2008).
Brown, L. L., Mitchell, U. A. & Ailshire, J. A. Disentangling the stress process: race/ethnic differences in the exposure and appraisal of chronic stressors among older adults. J. Gerontol. B Psychol. Sci. Soc. Sci. 75, 650–660 (2020).
Hatch, S. L. & Dohrenwend, B. P. Distribution of traumatic and other stressful life events by race/ethnicity, gender, SES and age: a review of the research. Am. J. Community Psychol. 40, 313–332 (2007).
Dahlhamer, J. M., Zammitti, E. P., Ward, B. W., Wheaton, A. G. & Croft, J. B. Prevalence of inflammatory bowel disease among adults aged ≥18 years – United States, 2015. MMWR Morb. Mortal. Wkly Rep. 65, 1166–1169 (2016).
Goonesekera, S. D., Dey, S., Thakur, S. & Davila, E. P. Racial/ethnic differences in autoimmune disease prevalence in US claims/EHR data. Am. J. Manag. Care 30, e4–e10 (2024).
Roshandel, G., Ghasemi-Kebria, F. & Malekzadeh, R. Colorectal cancer: epidemiology, risk factors, and prevention. Cancers 16, 1530 (2024).
Fedirko, V. et al. Alcohol drinking and colorectal cancer risk: an overall and dose-response meta-analysis of published studies. Ann. Oncol. 22, 1958–1972 (2011).
McNabb, S. et al. Meta-analysis of 16 studies of the association of alcohol with colorectal cancer. Int. J. Cancer 146, 861–873 (2020).
Botteri, E. et al. Smoking and colorectal cancer risk, overall and by molecular subtypes: a meta-analysis. Am. J. Gastroenterol. 115, 1940–1949 (2020).
IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Red Meat and Processed Meat (International Agency for Research on Cancer, 2018).
Domingo, J. L. & Nadal, M. Carcinogenicity of consumption of red meat and processed meat: a review of scientific news since the IARC decision. Food Chem. Toxicol. 105, 256–261 (2017).
Mahmood, S., MacInnis, R. J., English, D. R., Karahalios, A. & Lynch, B. M. Domain-specific physical activity and sedentary behaviour in relation to colon and rectal cancer risk: a systematic review and meta-analysis. Int. J. Epidemiol. 46, 1797–1813 (2017).
Butler, L. M. et al. Heterocyclic amines, meat intake, and association with colon cancer in a population-based study. Am. J. Epidemiol. 157, 434–445 (2003).
Zhao, Z. et al. Red and processed meat consumption and colorectal cancer risk: a systematic review and meta-analysis. Oncotarget 8, 83306–83314 (2017).
National Center for Chronic Disease Prevention and Health Promotion. Adult physical inactivity prevalence maps by race/ethnicity 2015–2018. CDC https://archive.cdc.gov/www_cdc_gov/physicalactivity/data/inactivity-prevalence-maps/2015-2018.html (2021).
Creamer, M. R. et al. Tobacco product use and cessation indicators among adults – United States, 2018. MMWR Morb. Mortal. Wkly Rep. 68, 1013–1019 (2019).
Office of the Surgeon General. Smoking Cessation: a Report of the Surgeon General (Department of Health and Human Services, 2020).
Agaku, I. T., Odani, S., Okuyemi, K. S. & Armour, B. Disparities in current cigarette smoking among US adults, 2002-2016. Tob. Control 29, 269–276 (2020).
Substance Abuse and Mental Health Services Administration. 2015 National Survey on Drug Use and Health: Detailed Tables (SAMHSA, 2016).
Dawson, D. A., Goldstein, R. B., Saha, T. D. & Grant, B. F. Changes in alcohol consumption: United States, 2001–2002 to 2012–2013. Drug Alcohol Depend. 148, 56–61 (2015).
Malone, P. S., Northrup, T. F., Masyn, K. E., Lamis, D. A. & Lamont, A. E. Initiation and persistence of alcohol use in United States Black, Hispanic, and White male and female youth. Addict. Behav. 37, 299–305 (2012).
Colditz, G. A., Cannuscio, C. C. & Frazier, A. L. Physical activity and reduced risk of colon cancer: implications for prevention. Cancer Causes Control. 8, 649–667 (1997).
Rezende, L. F. M. et al. Physical activity and cancer: an umbrella review of the literature including 22 major anatomical sites and 770 000 cancer cases. Br. J. Sports Med. 52, 826–833 (2018).
Purdue, M. P. et al. Hormone replacement therapy, reproductive history, and colorectal adenomas: data from the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening trial (United States). Cancer Causes Control 16, 965–973 (2005).
Chlebowski, R. T. et al. Estrogen plus progestin and colorectal cancer in postmenopausal women. N. Engl. J. Med. 350, 991–1004 (2004).
Kim, S. et al. Use of nonsteroidal antiinflammatory drugs and distal large bowel cancer in whites and African Americans. Am. J. Epidemiol. 168, 1292–1300 (2008).
Sansbury, L. B. et al. Use of nonsteroidal antiinflammatory drugs and risk of colon cancer in a population-based, case-control study of African Americans and Whites. Am. J. Epidemiol. 162, 548–558 (2005).
Cifuentes, L. & O’Keefe, S. Analysis of 1999-2017 NHANES data: minimal increase and racial disparities in U.S. fiber consumption over 18 years. Nutr. Cancer 76, 345–351 (2024).
Alegria-Lertxundi, I., Bujanda, L. & Arroyo-Izaga, M. Role of dairy foods, fish, white meat, and eggs in the prevention of colorectal cancer: a systematic review of observational studies in 2018-2022. Nutrients 14, 3430 (2022).
Zhang, X. et al. Calcium intake and colorectal cancer risk: results from the Nurses’ Health Study and health professionals follow-up study. Int. J. Cancer 139, 2232–2242 (2016).
Jin, S. & Je, Y. Nuts and legumes consumption and risk of colorectal cancer: a systematic review and meta-analysis. Eur. J. Epidemiol. 37, 569–585 (2022).
Puzzono, M. et al. The role of diet and lifestyle in early-onset colorectal cancer: a systematic review. Cancers 13, 5933 (2021).
International Agency for Research on Cancer. Vitamin D and Cancer. IARC Working Group Report Volume 5 (IARC, 2008).
Hargreaves, M. K., Baquet, C. & Gamshadzahi, A. Diet, nutritional status, and cancer risk in American blacks. Nutr. Cancer 12, 1–28 (1989).
Christmas, M. et al. Menopause hormone therapy and complementary alternative medicine, quality of life, and racial/ethnic differences: the Study of Women’s Health Across the Nation (SWAN). Menopause 29, 1357–1364 (2022).
Sanchez, N. F. et al. Physical activity reduces risk for colon polyps in a multiethnic colorectal cancer screening population. BMC Res. Notes 5, 312 (2012).
Veettil, S. K. et al. Role of diet in colorectal cancer incidence: umbrella review of meta-analyses of prospective observational studies. JAMA Netw. Open 4, e2037341 (2021).
Comerford, K. et al. The role of dairy food intake for improving health among black Americans across the life continuum: a summary of the evidence. J. Natl Med. Assoc. 116, 292–315 (2024).
Conti, L., Del Corno, M. & Gessani, S. Revisiting the impact of lifestyle on colorectal cancer risk in a gender perspective. Crit. Rev. Oncol. Hematol. 145, 102834 (2020).
Anderson, L. M. & May, D. S. Has the use of cervical, breast, and colorectal cancer screening increased in the United States? Am. J. Public Health 85, 840–842 (1995).
May, F. P., Yang, L., Corona, E., Glenn, B. A. & Bastani, R. Disparities in colorectal cancer screening in the United States before and after implementation of the Affordable Care Act. Clin. Gastroenterol. Hepatol. 18, 1796–1804.e2 (2020).
Rao, S. R., Breen, N. & Graubard, B. I. Trends in black–white disparities in breast and colorectal cancer screening rates in a changing screening environment: the Peters–Belson approach using United States National Health Interview Surveys 2000-2010. Med. Care 54, 133–139 (2016).
Rutter, C. M., Knudsen, A. B., Lin, J. S. & Bouskill, K. E. Black and white differences in colorectal cancer screening and screening outcomes: a narrative review. Cancer Epidemiol. Biomark. Prev. 30, 3–12 (2021).
Palaniappan, L. P. et al. Population colorectal cancer screening estimates: comparing self-report to electronic health record data in California. Int. J. Cancer Prev. 4, 28540 (2011).
Ferrante, J. M. et al. Self-report versus medical records for assessing cancer-preventive services delivery. Cancer Epidemiol. Biomark. Prev. 17, 2987–2994 (2008).
Powe, B. D. & Cooper, D. L. Self-reported cancer screening rates versus medical record documentation: incongruence, specificity, and sensitivity for African American women. Oncol. Nurs. Forum 35, 199–204 (2008).
Zhao, M. Y. et al. Colorectal cancer screening rates at federally qualified health centers from 2014 to 2022: incomplete recovery from COVID-19 and worsening disparities. Am. J. Gastroenterol. 119, 1580–1589 (2024).
Ebner, D. W. et al. Trends in colorectal cancer screening from the National Health Interview Survey: analysis of the impact of different modalities on overall screening rates. Cancer Prev. Res. 17, 275–280 (2024).
Zhu, X. et al. An examination of socioeconomic and racial/ethnic disparities in the awareness, knowledge and utilization of three colorectal cancer screening modalities. SSM Popul. Health 14, 100780 (2021).
Inadomi, J. M. et al. Adherence to colorectal cancer screening: a randomized clinical trial of competing strategies. Arch. Intern. Med. 172, 575–582 (2012).
Ruffin, M. T. T., Creswell, J. W., Jimbo, M. & Fetters, M. D. Factors influencing choices for colorectal cancer screening among previously unscreened African and Caucasian Americans: findings from a triangulation mixed methods investigation. J. Community Health 34, 79–89 (2009).
Doubeni, C. A. et al. Association between improved colorectal screening and racial disparities. N. Engl. J. Med. 386, 796–798 (2022).
Greiner, K. A., Born, W., Nollen, N. & Ahluwalia, J. S. Knowledge and perceptions of colorectal cancer screening among urban African Americans. J. Gen. Intern. Med. 20, 977–983 (2005).
Bastani, R., Gallardo, N. V. & Maxwell, A. E. Barriers to colorectal cancer screening among ethnically diverse high- and average-risk individuals. J. Psychosoc. Oncol. 19, 65–84 (2008).
Green, P. M. & Kelly, B. A. Colorectal cancer knowledge, perceptions, and behaviors in African Americans. Cancer Nurs. 27, 206–215 (2004).
Lipkus, I. M., Lyna, P. R. & Rimer, B. K. Colorectal cancer risk perceptions and screening intentions in a minority population. J. Natl Med. Assoc. 92, 492–500 (2000).
Lipkus, I. M. et al. Colorectal screening patterns and perceptions of risk among African-American users of a community health center. J. Community Health 21, 409–427 (1996).
Anyane-Yeboa, A. et al. Use of a mixed-methods approach to develop a guidebook with messaging to encourage colorectal cancer screening among black individuals 45 and older. Cancer Med. 12, 19047–19056 (2023).
Lasser, K. E., Ayanian, J. Z., Fletcher, R. H. & Good, M. J. Barriers to colorectal cancer screening in community health centers: a qualitative study. BMC Fam. Pract. 9, 15 (2008).
Bromley, E. G., May, F. P., Federer, L., Spiegel, B. M. & van Oijen, M. G. Explaining persistent under-use of colonoscopic cancer screening in African Americans: a systematic review. Prev. Med. 71, 40–48 (2015).
Muthukrishnan, M., Arnold, L. D. & James, A. S. Patients’ self-reported barriers to colon cancer screening in federally qualified health center settings. Prev. Med. Rep. 15, 100896 (2019).
Robillard, A. G. & Larkey, L. Health disadvantages in colorectal cancer screening among African Americans: considering the cultural context of narrative health promotion. J. Health Care Poor Underserved 20, 102–119 (2009).
White, P. M. & Itzkowitz, S. H. Barriers driving racial disparities in colorectal cancer screening in African Americans. Curr. Gastroenterol. Rep. 22, 41 (2020).
Roy, S. et al. Systematic review of interventions to increase stool blood colorectal cancer screening in African Americans. J. Community Health 46, 232–244 (2021).
Adams, L. B., Richmond, J., Corbie-Smith, G. & Powell, W. Medical mistrust and colorectal cancer screening among African Americans. J. Community Health 42, 1044–1061 (2017).
Bass, S. B. et al. Perceptions of colorectal cancer screening in urban African American clinic patients: differences by gender and screening status. J. Cancer Educ. 26, 121–128 (2011).
Hammond, W. P., Matthews, D., Mohottige, D., Agyemang, A. & Corbie-Smith, G. Masculinity, medical mistrust, and preventive health services delays among community-dwelling African-American men. J. Gen. Intern. Med. 25, 1300–1308 (2010).
Lumpkins, C. Y. et al. Marketing a healthy mind, body, and soul: an analysis of how African American men view the church as a social marketer and health promoter of colorectal cancer risk and prevention. Health Educ. Behav. 43, 452–460 (2016).
Beeker, C., Kraft, J., Goldman, R. & Jorgensen, C. Strategies for increasing colorectal cancer screening among African Americans. J. Psychosoc. Oncol. 19, 113–132 (2001).
Palmer, R. C., Midgette, L. A. & Dankwa, I. Colorectal cancer screening and African Americans: findings from a qualitative study. Cancer Control. 15, 72–79 (2008).
May, F. P., Almario, C. V., Ponce, N. & Spiegel, B. M. Racial minorities are more likely than whites to report lack of provider recommendation for colon cancer screening. Am. J. Gastroenterol. 110, 1388–1394 (2015).
Taylor, V. et al. Colorectal cancer screening among African Americans: the importance of physician recommendation. J. Natl Med. Assoc. 95, 806–812 (2003).
van Ryn, M. & Burke, J. The effect of patient race and socio-economic status on physicians’ perceptions of patients. Soc. Sci. Med. 50, 813–828 (2000).
Ge, G., Burke, N., Somkin, C. P. & Pasick, R. Considering culture in physician–patient communication during colorectal cancer screening. Qual. Health Res. 19, 778–789 (2009).
Fyffe, D. C., Hudson, S. V., Fagan, J. K. & Brown, D. R. Knowledge and barriers related to prostate and colorectal cancer prevention in underserved black men. J. Natl Med. Assoc. 100, 1161–1167 (2008).
Brandzel, S. et al. Latina and Black/African American women’s perspectives on cancer screening and cancer screening reminders. J. Racial Ethn. Health Disparities 4, 1000–1008 (2017).
Xierali, I. M. & Nivet, M. A. The racial and ethnic composition and distribution of primary care physicians. J. Health Care Poor Underserved 29, 556–570 (2018).
Faruque, F. S. et al. The impact of preventive screening resource distribution on geographic and population-based disparities in colorectal cancer in Mississippi. BMC Res. Notes 8, 423 (2015).
Rawl, S. M., Menon, U., Burness, A. & Breslau, E. S. Interventions to promote colorectal cancer screening: an integrative review. Nurs. Outlook 60, 172–181.e13 (2012).
Fedewa, S. A. et al. Racial and ethnic disparities in interval colorectal cancer incidence: a population-based cohort study. Ann. Intern. Med. 166, 857–866 (2017).
Mohl, J. T. et al. Rates of follow-up colonoscopy after a positive stool-based screening test result for colorectal cancer among health care organizations in the US, 2017–2020. JAMA Netw. Open 6, e2251384 (2023).
Kominski, G. F., Nonzee, N. J. & Sorensen, A. The Affordable Care Act’s impacts on access to insurance and health care for low-income populations. Annu. Rev. Public Health 38, 489–505 (2017).
Xu, M. R. et al. Impact of the Affordable Care Act on colorectal cancer outcomes: a systematic review. Am. J. Prev. Med. 58, 596–603 (2020).
Korshak, L. et al. National Veteran Health Equity Report: Colorectal Cancer Screening Information Brief (Veterans Health Administration, 2021).
Doubeni, C. A., Selby, K. & Levin, T. R. Disparities in preventable mortality from colorectal cancer: are they the result of structural racism? Gastroenterology 160, 1022–1025 (2021).
Nelson, A. R. Unequal treatment: report of the Institute of Medicine on racial and ethnic disparities in healthcare. Ann. Thorac. Surg. 76, S1377–S1381 (2003).
Bonjer, H. J. et al. A randomized trial of laparoscopic versus open surgery for rectal cancer. N. Engl. J. Med. 372, 1324–1332 (2015).
Fleshman, J. et al. Laparoscopic colectomy for cancer is not inferior to open surgery based on 5-year data from the COST Study Group trial. Ann. Surg. 246, 655–664 (2007).
Jiang, W. Z. et al. Short-term outcomes of laparoscopy-assisted vs open surgery for patients with low rectal cancer: the LASRE randomized clinical trial. JAMA Oncol. 8, 1607–1615 (2022).
Theophilus, M., Platell, C. & Spilsbury, K. Long-term survival following laparoscopic and open colectomy for colon cancer: a meta-analysis of randomized controlled trials. Colorectal Dis. 16, O75–O81 (2014).
Colon Cancer Laparoscopic or Open Resection Study Group Survival after laparoscopic surgery versus open surgery for colon cancer: long-term outcome of a randomised clinical trial. Lancet Oncol. 10, 44–52 (2009).
Bliton, J. N., Parides, M., Muscarella, P., Papalezova, K. T. & In, H. Understanding racial disparities in gastrointestinal cancer outcomes: lack of surgery contributes to lower survival in African American patients. Cancer Epidemiol. Biomark. Prev. 30, 529–538 (2021).
Ahuja, V. et al. Racial disparities in complications following elective colon cancer resection: impact of laparoscopic versus robotic approaches. Am. J. Surg. 227, 85–89 (2024).
Ahmed, F. A. et al. Disparities in treatment and survival for patients with isolated colorectal liver metastases. Surgery 172, 1629–1635 (2022).
Andre, T. et al. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N. Engl. J. Med. 350, 2343–2351 (2004).
Hu, H. et al. Neoadjuvant chemotherapy with oxaliplatin and fluoropyrimidine versus upfront surgery for locally advanced colon cancer: the randomized, phase III OPTICAL trial. J. Clin. Oncol. 42, 2978–2988 (2024).
Liang, Z. et al. The role of neoadjuvant chemotherapy in patients with locally advanced colon cancer: a systematic review and meta-analysis. Front. Oncol. 12, 1024345 (2022).
Sauer, R. et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N. Engl. J. Med. 351, 1731–1740 (2004).
Donnelly, M. et al. Total neoadjuvant therapy versus standard neoadjuvant treatment strategies for the management of locally advanced rectal cancer: network meta-analysis of randomized clinical trials. Br. J. Surg. 110, 1316–1330 (2023).
Kasi, A. et al. Total neoadjuvant therapy vs standard therapy in locally advanced rectal cancer: a systematic review and meta-analysis. JAMA Netw. Open 3, e2030097 (2020).
Chan, M., Rajasekar, G., Arnow, K. D., Wagner, T. H. & Dawes, A. J. Racial and ethnic disparities in access to total neoadjuvant therapy for rectal cancer. Surgery 176, 1058–1064 (2024).
Le, H., Ziogas, A., Lipkin, S. M. & Zell, J. A. Effects of socioeconomic status and treatment disparities in colorectal cancer survival. Cancer Epidemiol. Biomark. Prev. 17, 1950–1962 (2008).
Vassantachart, A., Marietta, M., Mehta, S., Lin, E. & Bian, S. X. Racial disparities and standard treatment in locally advanced rectal cancer: a National Cancer Database study. J. Gastrointest. Oncol. 13, 2922–2937 (2022).
Cheung, W. Y., Neville, B. A. & Earle, C. C. Etiology of delays in the initiation of adjuvant chemotherapy and their impact on outcomes for stage II and III rectal cancer. Dis. Colon Rectum 52, 1054–1064 (2009).
Andre, T. et al. Pembrolizumab in microsatellite-instability-high advanced colorectal cancer. N. Engl. J. Med. 383, 2207–2218 (2020).
Kopetz, S. et al. Encorafenib, binimetinib, and cetuximab in BRAF V600E-mutated colorectal cancer. N. Engl. J. Med. 381, 1632–1643 (2019).
Van Cutsem, E. et al. Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer. N. Engl. J. Med. 360, 1408–1417 (2009).
Manz, C. R. et al. Association of Oncologist participation in Medicare’s Oncology Care Model with patient receipt of novel cancer therapies. JAMA Netw. Open 5, e2234161 (2022).
Roberts, T. J. et al. Practice-level variation in molecular testing and use of targeted therapy for patients with non-small cell lung cancer and colorectal cancer. JAMA Netw. Open 6, e2310809 (2023).
Yoon, H. H. et al. Racial differences in BRAF/KRAS mutation rates and survival in stage III colon cancer patients. J. Natl Cancer Inst. 107, djv186 (2015).
Yousef, M. et al. Molecular, socioeconomic, and clinical factors affecting racial and ethnic disparities in colorectal cancer survival. JAMA Oncol. 10, 1519–1529 (2024).
Bruno, D. S., Hess, L. M., Li, X., Su, E. W. & Patel, M. Disparities in biomarker testing and clinical trial enrollment among patients with lung, breast, or colorectal cancers in the United States. JCO Precis. Oncol. 6, e2100427 (2022).
Dharwadkar, P. et al. Racial and ethnic disparities in germline genetic testing of patients with young-onset colorectal cancer. Clin. Gastroenterol. Hepatol. 20, 353–361.e3 (2022).
Lawler, T., Parlato, L. & Warren Andersen, S. Racial disparities in colorectal cancer clinicopathological and molecular tumor characteristics: a systematic review. Cancer Causes Control. 35, 223–239 (2024).
Best, A. L. et al. Structural racism and cancer: calls to action for cancer researchers to address racial/ethnic cancer inequity in the United States. Cancer Epidemiol. Biomark. Prev. 31, 1243–1246 (2022).
Trendowski, M. R. et al. Correlates of health-related quality of life in African Americans diagnosed with cancer: a review of survivorship studies and the Detroit research on cancer survivors cohort. Cancer Metastasis Rev. 43, 1373–1384 (2024).
Rabeneck, L., Souchek, J. & El-Serag, H. B. Survival of colorectal cancer patients hospitalized in the Veterans Affairs Health Care System. Am. J. Gastroenterol. 98, 1186–1192 (2003).
McCollum, A. D. et al. Outcomes and toxicity in African-American and Caucasian patients in a randomized adjuvant chemotherapy trial for colon cancer. J. Natl Cancer Inst. 94, 1160–1167 (2002).
Beaver, K., Bogg, J. & Luker, K. A. Decision-making role preferences and information needs: a comparison of colorectal and breast cancer. Health Expect. 2, 266–276 (1999).
Beaver, K. et al. Colorectal cancer patients’ attitudes towards involvement in decision making. Health Expect. 12, 27–37 (2009).
Beaver, K. et al. Patient participation in decision making: views of health professionals caring for people with colorectal cancer. J. Clin. Nurs. 16, 725–733 (2007).
Beaver, K. et al. Exploring the decision-making preferences of people with colorectal cancer. Health Expect. 8, 103–113 (2005).
Berry, J. et al. Examining racial disparities in colorectal cancer care. J. Psychosoc. Oncol. 27, 59–83 (2009).
Berry, J. et al. A black–white comparison of the quality of stage-specific colon cancer treatment. Cancer 116, 713–722 (2010).
Busch, E. L., Martin, C., DeWalt, D. A. & Sandler, R. S. Functional health literacy, chemotherapy decisions, and outcomes among a colorectal cancer cohort. Cancer Control. 22, 95–101 (2015).
Chagpar, R. et al. Adherence to stage-specific treatment guidelines for patients with colon cancer. J. Clin. Oncol. 30, 972–979 (2012).
Cranley, N. M., Curbow, B., George, T. J. Jr. & Christie, J. Influential factors on treatment decision making among patients with colorectal cancer: a scoping review. Support. Care Cancer 25, 2943–2951 (2017).
Javier-DesLoges, J. et al. Disparities and trends in the participation of minorities, women, and the elderly in breast, colorectal, lung, and prostate cancer clinical trials. Cancer 128, 770–777 (2022).
Pittell, H. et al. Racial and ethnic inequities in US oncology clinical trial participation from 2017 to 2022. JAMA Netw. Open 6, e2322515 (2023).
Coughlin, S. E. et al. Multigene panel testing yields high rates of clinically actionable variants among patients with colorectal cancer. JCO Precis. Oncol. 6, e2200517 (2022).
Kupfer, S. S. et al. Genetic heterogeneity in colorectal cancer associations between African and European Americans. Gastroenterology 139, 1677–1685.e8 (2010).
Kupfer, S. S. et al. Shared and independent colorectal cancer risk alleles in TGFβ-related genes in African and European Americans. Carcinogenesis 35, 2025–2030 (2014).
Holowatyj, A. N. et al. Racial/ethnic and sex differences in somatic cancer gene mutations among patients with early-onset colorectal cancer. Cancer Discov. 13, 570–579 (2023).
Rhead, B. et al. Association of genetic ancestry with molecular tumor profiles in colorectal cancer. Genome Med. 16, 99 (2024).
Guda, K. et al. Novel recurrently mutated genes in African American colon cancers. Proc. Natl Acad. Sci. USA 112, 1149–1154 (2015).
Jovov, B. et al. Differential gene expression between African American and European American colorectal cancer patients. PLoS ONE 7, e30168 (2012).
Devall, M. et al. Racial disparities in epigenetic aging of the right vs left colon. J. Natl Cancer Inst. 113, 1779–1782 (2021).
Liang, P. S., Williams, J. L., Dominitz, J. A., Corley, D. A. & Zauber, A. G. Age-stratified prevalence and predictors of neoplasia among U.S. adults undergoing screening colonoscopy in a national endoscopy registry. Gastroenterology 163, 742–753.e4 (2022).
Corley, D. A. et al. Variation of adenoma prevalence by age, sex, race, and colon location in a large population: implications for screening and quality programs. Clin. Gastroenterol. Hepatol. 11, 172–180 (2013).
Jackson, C. S. & Vega, K. J. Higher prevalence of proximal colon polyps and villous histology in African-Americans undergoing colonoscopy at a single equal access center. J. Gastrointest. Oncol. 6, 638–643 (2015).
Wallace, K. et al. Race and prevalence of large bowel polyps among the low-income and uninsured in South Carolina. Dig. Dis. Sci. 61, 265–272 (2016).
Lieberman, D. A. et al. Prevalence of colon polyps detected by colonoscopy screening in asymptomatic black and white patients. JAMA 300, 1417–1422 (2008).
Laiyemo, A. O. et al. Occurrence of distal colorectal neoplasia among Whites and Blacks following negative flexible sigmoidoscopy: an analysis of PLCO trial. J. Gen. Intern. Med. 30, 1447–1453 (2015).
Allford, A., Qureshi, N., Barwell, J., Lewis, C. & Kai, J. What hinders minority ethnic access to cancer genetics services and what may help? Eur. J. Hum. Genet. 22, 866–874 (2014).
Lin, J., Qiu, M., Xu, R. & Dobs, A. S. Comparison of survival and clinicopathologic features in colorectal cancer among African American, Caucasian, and Chinese patients treated in the United States: results from the Surveillance Epidemiology and End Results (SEER) database. Oncotarget 6, 33935–33943 (2015).
Shavers, V. L. Racial/ethnic variation in the anatomic subsite location of in situ and invasive cancers of the colon. J. Natl Med. Assoc. 99, 733–748 (2007).
Azar, I., Esfandiarifard, S., Sinai, P. & Mehdi, S. Colon cancer survival in the US Department of Veterans Affairs by race and stage: 2001 through 2009. Cancer 124, 2858 (2018).
Dietrich, A. J. et al. Telephone care management to improve cancer screening among low-income women: a randomized, controlled trial. Ann. Intern. Med. 144, 563–571 (2006).
Itzkowitz, S. H. et al. New York citywide colon cancer control coalition: a public health effort to increase colon cancer screening and address health disparities. Cancer 122, 269–277 (2016).
Weng, O. Colorectal cancer prevention: timely colonoscopy screening among New Yorkers ages 50 and older. NYC Vital Signs 18, 1–4 (2020).
Delaware Cancer Consortium. Delaware past reports available from Cancer Consortium. Delaware.gov https://dhss.delaware.gov/dhss/dph/dpc/consortium.html (2008).
Delaware Health and Social Services. Testing for breast, cervical, prostate, lung, and colorectal cancer. Delaware.gov https://dhss.delaware.gov/dhss/dph/dpc/sfl.html (2025).
Delaware Health and Social Services. Cancer treatment program provides financial help for uninsured patients. Delaware.gov https://dhss.delaware.gov/dhss/dph/dpc/catreatment.html (2025).
Obrochta, C. A., Murphy, J. D., Tsou, M. H. & Thompson, C. A. Disentangling racial, ethnic, and socioeconomic disparities in treatment for colorectal cancer. Cancer Epidemiol. Biomark. Prev. 30, 1546–1553 (2021).
Abdel-Rahman, O. Outcomes of non-metastatic colon cancer patients in relationship to socioeconomic status: an analysis of SEER census tract-level socioeconomic database. Int. J. Clin. Oncol. 24, 1582–1587 (2019).
Acknowledgements
The authors thank K. Heskett and J. J. Tuan for their assistance with the literature search for this article. The authors also thank E. Schafer for statistical support. This material is the result of work supported in part by resources from the Veterans Health Administration. The content is solely the responsibility of the authors and does not represent the views of the Department of Veterans Affairs or the US Government. F.P.M. is supported by National Cancer Institute grant R01CA271034 (to F.P.M.), Department of Veterans Affairs Health Services Research and Development grant 10I01HX003605 (to S.G. and F.P.M.), Stand up to Cancer, and the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research Ablon Scholars Program. W.T.M. is supported by National Institutes of Health grant KL2 TR001444 (to W.T.M.), Robert Wood Johnson Foundation Harold Amos Medical Faculty Development Program, and Bristol Myers Squibb Robert A. Winn Career Development Award. A.J. is supported by Intramural Research, American Cancer Society. S.G. is supported by National Cancer Institute grant R37 MERIT CA222866 (to S.G.) and Department of Veterans Affairs Health Services Research and Development grants 5I01HX001574 (to S.G.) and 1I01HX003605 (to F.P.M. and S.G.).
Author information
Authors and Affiliations
Contributions
The authors contributed equally to all aspects of the article.
Corresponding author
Ethics declarations
Competing interests
F.P.M. is a medical adviser for Exact Sciences, Medtronic, Freenome, Geneoscopy, Guardant Health, InterVenn and Natura. S.G. is a medical adviser for Geneoscopy, Guardant Health, Universal Diagnostics, InterVenn and CellMax; and has received research support from Freenome and Exact Sciences. The other authors declare no competing interests.
Peer review
Peer review information
Nature Reviews Gastroenterology & Hepatology thanks Jonathan Laryea and the other, anonymous, reviewer(s) for their contribution to the peer review of this work.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Related links
Delaware Cancer Control: https://dhss.delaware.gov/dph/dpc/cancer.html
Kaiser Permanente Northern California: https://about.kaiserpermanente.org
National Cancer Institute Cancer trends progress report: https://progressreport.cancer.gov
New York Citywide Colon Cancer Control Coalition: https://www.nyc.gov/site/doh/providers/resources/citywide-colon-cancer-control-coalition.page
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
May, F.P., Mehtsun, W.T., Jemal, A. et al. Black–White disparities across the colorectal cancer care continuum in the USA. Nat Rev Gastroenterol Hepatol 22, 603–618 (2025). https://doi.org/10.1038/s41575-025-01087-3
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/s41575-025-01087-3